http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021213289-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d513047a69959e8d66a82d24b8c9de35
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36139
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36064
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-36
filingDate 2021-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4c0db01b36b1ae56cb29826f307a3da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4cc2403514a4bd5bbcdb7e973e646e2
publicationDate 2021-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2021213289-A1
titleOfInvention Cranial nerve stimulation to treat seizure disorders
abstract A method includes applying, by an implantable medical device (IMD), stimulation to a cranial nerve of a patient responsive to a determination that a level of synchrony between neural activity of one or more regions of an autonomic nervous system of the patient and one or more regions of a central nervous system of the patient falls below a first threshold and discontinuing the application of stimulation by the IMD when the level of synchrony exceeds a second threshold.
priorityDate 2013-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395300
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7057995
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91670

Total number of triples: 19.